Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis
Therapeutic Equivalence of Diclofenac Sodium Gel 3% and Solaraze ®, in the treatment of Actinic Keratosis
Actinic Keratoses
DRUG: Diclofenac Sodium Gel|DRUG: Solaraze 3% Topical Gel|OTHER: Placebo
proportion of patients in each treatment group with 100% clearance of all AK Lesions, Day 90 (30 days after completion of a 60 day treatment)|Superiority of the test and reference products against the placebo, Day 90 (30 days after completion of a 60 day treatment)
A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel 3% (Encube Ethicals) Compared to Solaraze® (diclofenac sodium) Gel 3% (Fougera Pharmaceuticals Inc.) in the Treatment of Actinic Keratosis